Product: Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.
Reason for recall: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Recall initiated: 20191122
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated